Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Hyperdiploid multiple myeloma (H-MM) represents the most prevalent subtype of multiple myeloma.
• Understanding the molecular drivers of H-MM is crucial for improving patient outcomes.

Purpose of the Study:

• To define the molecular signatures of H-MM using gene expression profiling.
• To identify distinct patient clusters within H-MM based on gene expression patterns.
• To investigate the biological and clinical significance of these identified clusters.

Main Methods:

• Gene expression profiling of H-MM patient samples.
• Bioinformatic analysis to identify gene expression signatures and patient clusters.
• Validation of identified clusters and correlation with clinical parameters such as proliferation index, treatment response, and survival.

Main Results:

• H-MM is characterized by a protein biosynthesis signature driven by gene dosage from trisomic chromosomes.
• Four distinct patient clusters were identified, each overexpressing unique gene sets involved in specific pathways.
• Cluster 1 showed high expression of cancer testis antigens and proliferation genes, correlating with higher tumor proliferation.
• Cluster 3 exhibited enrichment of TNF/NF-κB signaling and antiapoptotic genes, associated with better response to bortezomib.
• A subset of patients within cluster 1, despite a generally better prognosis, exhibited short survival (median 27 months).

Conclusions:

• H-MM exhibits significant molecular heterogeneity, challenging the notion of a uniform prognosis.
• Cytogenetic factors and specific gene expression signatures are important prognostic indicators in H-MM.
• Identified molecular signatures may guide personalized treatment strategies for H-MM patients.